Latest Breaking News On - Benign hematology - Page 1 : comparemela.com

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesGuenther koehneMiami cancer instituteBaptist healthMarrow transplantHematologic oncologyBenign hematology

Dr Koehne on Efforts to Overcome CAR T-Cell Resistance in Hematologic Malignancies

Guenther Koehne, MD, PhD, discusses research efforts to overcome resistance to CAR T-cell therapy in hematologic malignancies.

United statesGuenther koehneBaptist healthMiami cancer instituteMarrow transplantHematologic oncologyBenign hematologyBaptist health wellness and medical complexCancer careHematologic malignanciesCart cell therapy

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesIowa cityDana farber cancer instituteUniversity of texas southwestern medical centerUniversity of iowaNew yorkMemorial sloan kettering cancer centerEunices wangEunice wangFred hutchinson cancer centerArog pharmaceuticals of dallasRoswell park comprehensive cancer centerCity of hope national medical centerBenign hematologyRoswell parkNewly diagnosed

Novel Treatment Regimen for FLT3-Mutated Acute Myeloid Leukemia Shows Promise in Roswell Park-Led Study

Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very p

United statesUniversity of iowaMemorial sloan kettering cancer centerNew yorkDana farber cancer instituteIowa cityUniversity of texas southwestern medical centerEunice wangRoswell parkArog pharmaceuticalsAmerican society of clinical oncologyRoswell park care networkFred hutchinson cancer centerCity of hope national medical centerNational cancerArog pharmaceuticals of dallas

Novel Treatment Regimen for FLT3-Mutated Acute Myeloid Leukemia Shows Promise in Roswell Park-Led Study

Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very p

University of iowaUnited statesMemorial sloan kettering cancer centerNew yorkDana farber cancer instituteIowa cityUniversity of texas southwestern medical centerRoswell parkEunice wangCity of hope national medical centerNational cancerArog pharmaceuticals of dallasRoswell park comprehensive cancer centerArog pharmaceuticalsAmerican society of clinical oncologyFred hutchinson cancer center